Literature DB >> 5713638

Diagnostic and genetical aspects of tuberous sclerosis.

N C Nevin, W G Pearce.   

Abstract

Entities:  

Mesh:

Year:  1968        PMID: 5713638      PMCID: PMC1468678          DOI: 10.1136/jmg.5.4.273

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  13 in total

1.  Internal manifestations of tuberous sclerosis.

Authors:  W B REED; W R NICKEL; G CAMPION
Journal:  Arch Dermatol       Date:  1963-06

2.  Congenital neurocutaneous syndromes in childhood.

Authors:  D H CHAO
Journal:  J Pediatr       Date:  1959-10       Impact factor: 4.406

3.  Achondroplasia: an account of the condition in Northern Ireland.

Authors:  A C STEVENSON
Journal:  Am J Hum Genet       Date:  1957-03       Impact factor: 11.025

4.  Marfan's syndrome in Northern Ireland; an account of thirteen families.

Authors:  M A LYNAS
Journal:  Ann Hum Genet       Date:  1958-07       Impact factor: 1.670

5.  Pulmonary tuberous sclerosis and its relationship to other forms of the disease.

Authors:  J DAWSON
Journal:  Q J Med       Date:  1954-04

6.  [Tuberous cerebral sclerosis of Bourneville].

Authors:  J FRANCOIS; J P DEWEER
Journal:  Ophthalmologica       Date:  1952-12       Impact factor: 3.250

7.  Tuberous sclerosis: reappraisal of a clinical entity.

Authors:  J C Lagos; M R Gomez
Journal:  Mayo Clin Proc       Date:  1967-01       Impact factor: 7.616

8.  Infantile spasms and skin anomalies.

Authors:  J U Crichton
Journal:  Dev Med Child Neurol       Date:  1966-06       Impact factor: 5.449

9.  DEPIGMENTED NEVI: THE EARLIEST SIGN OF TUBEROUS SCLEROSIS.

Authors:  A P GOLD; J M FREEMAN
Journal:  Pediatrics       Date:  1965-06       Impact factor: 7.124

10.  Apert's syndrome (a type of acrocephalosyndactyly)-observations on a British series of thirty-nine cases.

Authors:  C E BLANK
Journal:  Ann Hum Genet       Date:  1960-05       Impact factor: 1.670

View more
  19 in total

1.  Evidence for genetic heterogeneity in tuberous sclerosis: one locus on chromosome 9 and at least one locus elsewhere.

Authors:  H Northrup; D J Kwiatkowski; E S Roach; W B Dobyns; R A Lewis; G E Herman; E Rodriguez; S P Daiger; S H Blanton
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

2.  Serum and tissue proteins in tuberous sclerosis. I. Serum and red-cell polymorphic systems.

Authors:  A T Rundle; J Atkin; B Sudell
Journal:  Humangenetik       Date:  1975

3.  Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference.

Authors:  Hope Northrup; Darcy A Krueger
Journal:  Pediatr Neurol       Date:  2013-10       Impact factor: 3.372

4.  Genetic aspects of tuberous sclerosis in the west of Scotland.

Authors:  J R Sampson; S J Scahill; J B Stephenson; L Mann; J M Connor
Journal:  J Med Genet       Date:  1989-01       Impact factor: 6.318

5.  Primitive neuroectodermal tumor in a child with tuberous sclerosis.

Authors:  B W Hindman; H K Gill; C W Zuppan
Journal:  Skeletal Radiol       Date:  1997-03       Impact factor: 2.199

6.  Pulmonary manifestations of tuberous sclerosis in first degree relatives.

Authors:  J M Slingerland; R F Grossman; D Chamberlain; C E Tremblay
Journal:  Thorax       Date:  1989-03       Impact factor: 9.139

7.  Evidence for population variation in TSC1 and TSC2 gene expression.

Authors:  Garilyn M Jentarra; Stephen G Rice; Shannon Olfers; David Saffen; Vinodh Narayanan
Journal:  BMC Med Genet       Date:  2011-02-23       Impact factor: 2.103

8.  Palmar dermatoglyphs in tuberous sclerosis.

Authors:  T J David
Journal:  J Med Genet       Date:  1972-12       Impact factor: 6.318

9.  Tuberous sclerosis: a genetic study.

Authors:  S Bundey; K Evans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-12       Impact factor: 10.154

10.  Risk estimation in autosomal dominant disorders with reduced penetrance.

Authors:  A E Emery
Journal:  J Med Genet       Date:  1986-08       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.